In this study, we evaluated the prognostic ability of uPAR expression in patients with grade 2–4 gliomas as uPAR expression has been previously been shown to add valuable prognostic information to solid cancers independent of other grading systems such as WHO [17, 35]. The gene discussed is PLAUR; the disease is central nervous system cancer.